| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $957.8M | +31.8% |
| Cost of Revenue | $81.8M | +96.6% |
| R&D Expense | $303.2M | -13.8% |
| SG&A Expense | $488.4M | +20.1% |
| Operating Income | $230.8M | +414.5% |
| Pre-tax Income | $258.1M | +605.7% |
| Income Tax | $31.6M | +208.5% |
| Net Income | $226.5M | +469.5% |
| EPS (Basic) | $1.37 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $319.6M | +69.4% |
| Accounts Receivable | $98.7M | +0.5% |
| Inventory | $91.7M | +126.7% |
| Current Assets | $938.3M | +52.3% |
| Total Assets | $1.19B | +58.6% |
| Current Liabilities | $394.9M | +55.3% |
| Total Liabilities | $455.0M | +43.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $157.7M | +844.3% |
| Capital Expenditures | $523K | +946.0% |
| Investing Cash Flow | -$30.5M | -195.4% |
| Financing Cash Flow | $6.8M | -72.8% |
| Free Cash Flow | $157.2M | +844.0% |
| +470.3% |
| EPS (Diluted) | $1.36 | +467.6% |
| Stockholders' Equity |
| $732.8M |
| +69.7% |